Idenix Pharmaceuticals, Inc.Cambridge, MA, United States (NASDAQ (GM): IDIX)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Idenix Pharmaceuticals Financial Statements

Idenix Pharmaceuticals Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Idenix Pharmaceuticals Income Statement

  2007 2006 2005
Revenue ($ mil.) 68.0 67.4 64.7
Gross Profit ($ mil.) 66.0 67.3 --
Operating Income ($ mil.) (91.9) (85.7) (55.5)
Total Net Income ($ mil.) (82.5) (75.1) (50.8)
Diluted EPS (Net Income) (1.47) (1.34) (1.03)
More Idenix Pharmaceuticals financial information

Idenix Pharmaceuticals Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 1.6 2.0 12.6
Gross Profit ($ mil.) 1.2 1.6 11.1
Operating Income ($ mil.) (19.6) (21.8) (20.8)
Total Net Income ($ mil.) (18.9) (20.5) (17.5)
Diluted EPS (Net Income) (0.34) (0.36) (0.31)
More Idenix Pharmaceuticals financial information

Idenix Pharmaceuticals Stock Quote & Chart

09/05/08 10:43:30 EST • NASDAQ • 8.75 • Decreased by -0.1400 • Decreased by -1.5748 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Idenix Pharmaceuticals Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 17.74 3.51 1.54
Price/Earnings Ratio -- 15.32 15.62
Price/Book Ratio 12.11 2.89 1.49
Price/Cash Flow Ratio -- 12.48 9.59
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Idenix Pharmaceuticals Financial Ratios

Idenix Pharmaceuticals Competitive Intelligence

Bristol-Myers Squibb Gilead Sciences GlaxoSmithKline
Annual Sales ($ mil.) 19,348.0 4,230.0 22,716.0
Employees 42,000 2,979 103,401
Market Cap ($ mil.) 43,230.6 50,393.4 --

Competitive Landscape